Onglyza MDL Awaiting Approval Status
Onglyza MDL Awaiting Approval Status
Introduction
Another heart failure lawsuit filed recently now awaits a nod for from the U.S. Judicial Panel on Multidistrict Litigation for centralization of all federally-filed Onglyza and Kombiglyze XR lawsuits in a single U.S. District Court for coordinated pretrial proceedings. The number of lawsuits filed has already crossed 40 and is expected to eventually grow to include hundreds of similar cases.
The JPML was scheduled to hear oral arguments on January 25, 2018, to decide whether consolidation was necessary or not. The court records show more than 42 product liability lawsuits pending in the federal court system filed by individuals who developed congestive heart failure and other side effects of diabetes drug.
Comments
Latest News
Lawyers to Meet Nov. 5 for Talcum Powder Trial Prep
Categories: Talcum
As the first federal talcum powder bellwether trial approaches, both plaintiffs and defendants have finalized their legal teams and are preparing for a key pretrial conference scheduled for early November.
The upcoming proceedings mark a…
2025 Update: What to Know About PPI Lawsuit Settlements & Payout Dates
Categories: Settlements
Last updated on Oct 27, 2025.
The mass tort litigation involving proton pump inhibitor (PPI) drugs — such as Nexium, Prilosec, Prevacid and Protonix — is entering a pivotal phase in …
New Front Emerges in Fight Against Synthetic Opioids
Categories: Opioids
The U.S. opioid crisis has already claimed hundreds of thousands of lives, with fentanyl standing out as one of the deadliest substances. Now the leading cause of death among Americans aged 18 to 44, fentanyl has become synonymous with overdose…